Ektomab (TRBS07)
/ Trion Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 22, 2021
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma.
(PubMed, J Immunother Cancer)
- "Here we provide proof-of-concept for EKTOMUN preclinical efficacy against neuroblastoma, presenting this bispecific trAb as a promising new agent to fight neuroblastoma."
Journal • Preclinical • Immunology • Neuroblastoma • Oncology • Pediatrics • Solid Tumor • CD4 • CD8
1 to 1
Of
1
Go to page
1